UnitedHealth Group (NYSE:UNH) CEO Sells $455,910.00 in Stock

UnitedHealth Group Incorporated (NYSE:UNH) CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Patrick Hugh Conway also recently made the following trade(s):

• On Wednesday, August 5th, Patrick Hugh Conway sold 500 shares of UnitedHealth Group stock. The shares were sold at an average price of $410.00, for a total value of $205,000.00.

UnitedHealth Group Stock Down 1.6%

Shares of UNH stock opened at $394.57 on Friday. The stock’s fifty day moving average price is $413.42 and its 200 day moving average price is $359.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a market cap of $354.16 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of UNH. HORAN Wealth LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $285,000. Principia Wealth Advisory LLC boosted its stake in shares of UnitedHealth Group by 55.0% during the 2nd quarter. Principia Wealth Advisory LLC now owns 93 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 33 shares in the last quarter. HighTower Advisors LLC raised its stake in shares of UnitedHealth Group by 12.0% during the 2nd quarter. HighTower Advisors LLC now owns 682,746 shares of the healthcare conglomerate’s stock worth $283,770,000 after buying an additional 73,003 shares during the period. Advus Financial Partners LLC raised its position in UnitedHealth Group by 27.6% during the second quarter. Advus Financial Partners LLC now owns 1,208 shares of the healthcare conglomerate’s stock worth $502,000 after acquiring an additional 261 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $64,231,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNH. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their price objective for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Bank of America restated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. Finally, Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $456.56.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.